Welcome to our dedicated page for Calumet SEC filings (Ticker: CLMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Calumet, Inc. filings document operating results, governance matters and capital-structure actions for a Nasdaq-listed specialty products and renewable fuels company. The record includes Form 8-K disclosures for quarterly and annual results, Regulation FD communications, material definitive agreements, credit-agreement amendments, direct financial obligations and senior-note transactions involving subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp.
Proxy materials describe annual meeting voting matters, board elections and related governance disclosures. The filings also identify Calumet's common stock, par value $0.01 per share, under symbol CLMT on The Nasdaq Stock Market LLC and provide formal disclosure around debt terms, covenant changes, risk-related governance and shareholder matters.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer received a grant of 6,092 Restricted Stock Units (RSUs). Each RSU represents one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting, and will be settled in shares at vesting. Following this grant, Mawer holds 6,092 RSUs directly.
Schumacher Amy M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Amy M. Schumacher received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock, par value $0.01 per share.
The RSUs vest on the earlier of June 2, 2027 or the date of Calumet’s 2027 Annual Meeting, and will be settled upon vesting. Following this compensation award, Schumacher holds 3,461 RSUs directly.
Sajkowski Daniel J reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Daniel J. Sajkowski received a grant of 3,461 Restricted Stock Units, each economically equivalent to one share of common stock. This is a stock-based compensation award rather than an open-market trade. Following the grant, he holds 3,461 units directly.
The Restricted Stock Units vest on the earlier of June 2, 2027 or the date of Calumet, Inc.’s 2027 Annual Meeting, and will be settled in shares upon vesting. This aligns director compensation with future company performance over the next several years.
NARWOLD KAREN G reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Karen G. Narwold received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock. These RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.
Calumet, Inc. reported voting results from its 2026 Annual Meeting of Stockholders held on June 2, 2026. Stockholders elected three Class II directors—Todd Borgmann, Daniel J. Sajkowski, and Bradford T. Sanders—to serve until the 2029 annual meeting.
Support for the director nominees ranged from 50,332,470 to 51,130,433 votes in favor, with 19,926,638 broker non-votes recorded for each nominee. Stockholders also approved, on a non-binding advisory basis, the Company’s executive compensation, with 50,222,235 votes for, 956,685 against, and 276,087 abstentions.
In addition, stockholders ratified the selection of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2026, receiving 70,973,872 votes for, 194,987 against, and 212,786 abstentions.
Mawer Stephen P reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Stephen P. Mawer reported receiving two grants of restricted stock units on May 28, 2026. He was awarded 322 restricted stock units and a separate grant of 968 units, each economically equivalent to one share of common stock.
The 322 restricted stock units are 100% vested and will be settled in shares upon the earlier of a date he specifies or his termination date. The 968 restricted stock units will be settled under the Deferred Compensation Plan on the earlier of a specified date or termination, with 25% vesting each July 1 beginning in 2027.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss reported compensation-related equity grants. On 2026-05-28, he received two awards totaling 281 Restricted Stock Units, each economically equivalent to one share of Calumet common stock.
One 70-unit award is 100% vested and will be settled upon the earlier of a date he specifies or his termination date. The 211-unit award is granted under the Deferred Compensation Plan, with 25% of the units vesting on July 1 each year beginning on July 1, 2027, and settlement also occurring upon the earlier of his specified date or termination.
Raymond Paul C reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Raymond Paul C reported compensation-related equity grants. On May 28, 2026, he received two awards of Calumet Restricted Stock Units (RSUs) that are each economically equivalent to common shares of Calumet, Inc. common stock.
The first grant covers 234 RSUs, is 100% vested, and results in total holdings of 234 RSUs from that award. The second grant covers 704 RSUs, with 25% vesting each July 1 beginning on July 1, 2027, and total holdings of 704 RSUs from that award.
Both RSU awards have a grant price of $0.00 per unit and will settle in stock upon the earlier of a date specified by the reporting person or his termination date under the company’s deferred compensation plan.
Schumacher Amy M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Amy M. Schumacher reported compensation-related equity grants in the form of restricted stock units. On May 28, 2026, she received two awards covering 214 and 644 restricted stock units, each economically equivalent to one share of Calumet common stock.
The 214-unit award is fully vested and will be settled in shares on the earlier of a date she specifies or her termination. The 644-unit award is under the company’s Deferred Compensation Plan, with 25% of those units vesting on July 1 of each year beginning in 2027, and settling on the earlier of a specified date or termination.
Heritage Group, a 10% owner of Calumet, Inc., reported a cashless exercise of warrants to purchase 1,020,000 shares of common stock at $20.00 per share. The issuer withheld 626,998 shares to pay the exercise price and issued the remaining 393,002 shares of common stock to the reporting person.
After these transactions, the filing shows 13,607,209 shares of common stock held directly, plus 1,200,000 shares owned by The Heritage Group Investment Company, LLC and 882,974 shares held by Calumet, Incorporated, both attributed as indirect holdings with beneficial ownership disclaimed except for any pecuniary interest.